[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 16, Issue 38, 22 September 2011

Perspectives
Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010



M Navarro<SUP>1</SUP>, A Perez-Ayala<SUP>1</SUP>, A Guionnet<SUP>1</SUP>, J A Perez-Molina<SUP>1</SUP>, B Navaza<SUP>1</SUP>, L Estévez<SUP>1</SUP>, F Norman<SUP>1</SUP>, M Flores-Chávez<SUP>2</SUP>, R Lopez-Velez ()<SUP>1</SUP>
  1. Tropical Medicine and Clinical Parasitology, Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain
  2. Parasitology Department, National Microbiology Centre (CNM), Instituto de Salud Carlos III, Madrid, Spain
<HR>
Citation style for this article: Navarro M, Perez-Ayala A, Guionnet A, Perez-Molina JA, Navaza B, Estévez L, Norman F, Flores-Chávez M, Lopez-Velez R. Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010. Euro Surveill. 2011;16(38):pii=19973. Available online: http://www.eurosurveillance.org/View...rticleId=19973
Date of submission: 25 February 2011
<HR>Chagas disease is endemic in Latin America, but migration has expanded the disease’s geographical limits. Spain is the most affected country in Europe. From 2007, a specific Chagas disease programme aimed at at-risk migrants was developed in three Spanish cities (Madrid, Jerez de la Frontera and Alicante). The objectives of the programme were to increase participants’ knowledge and decrease their fears about the disease and to encourage them to undergo screening for Trypanosoma cruzi infection. The programme was specially focused on migrants from Bolivia and Latin American women of childbearing age. Culturally tailored interventions were carried out in non-clinical settings. A total of 276 migrants were screened using a rapid immunochromatographic test following talks on the disease: the results were then later confirmed by standard serological tests. Of those tested, 44 (15.9%) were confirmed cases of Chagas disease. All of them came from Bolivia and a quarter were pregnant women. Of the 44 cases, 31 were later followed up at a specialised Chagas disease clinic. We consider that the adaptation of the programme to the target population’s needs and collaboration with non-governmental organisations and migrants’ associations contributed to the acceptance of the programme and the increasing number of patients seen at a specialised clinic.
- -------